Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health Inc.

UBS analyst Levi Spry upgraded Evolution Mining to a Buy today and set a price target of A$14.00. According to TipRanks, Spry is a 5-star analyst w...

Positive Report for Evolution Mining  (CAHPF) from UBS

Analysts have been eager to weigh in on the Materials sector with new ratings on Evolution Mining (CAHPF) and Orica Limited (OCLDF). Evolution Mini...

Analysts Offer Insights on Materials Companies: Evolution Mining (OtherCAHPF) and Orica Limited (OtherOCLDF)

Morgan Stanley analyst Erin Wright reiterated a Buy rating on Cardinal Health today and set a price target of $255.00. Wright covers the Healthcare...

Cardinal Health (CAH) Gets a Buy from Morgan Stanley

Analysts fell to the sidelines weighing in on Eldorado Gold (EGO) and Evolution Mining (CAHPF) with neutral ratings, indicating that the experts ar...

Analysts Offer Insights on Materials Companies: Eldorado Gold (EGO) and Evolution Mining (OtherCAHPF)

The latest update is out from Evolution Mining ( ($AU:EVN) ). Evolution Mining has released a presentation for the Macquarie Australia Conference 2...

Evolution Mining outlines growth ambitions and flags risks at Macquarie conference

Analysts are intrested in these 5 stocks: ( ($CAH) ), ( ($MCK) ), ( ($ZETA) ), ( ($CNC) ) and ( ($ABAT) ). Here is a breakdown of their recent


Cardinal, McKesson, Zeta, Centene, ABAT Trending With Analysts

In a report released today, Elizabeth Anderson CFA from Evercore ISI reiterated a Buy rating on Cardinal Health, with a price target of $240.00. An...

Evercore ISI Remains a Buy on Cardinal Health (CAH)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (ILMN) and Cardinal Health (CAH). Illumina (ILMN) In a r...

Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Cardinal Health (CAH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cardinal Health (CAH) and Illumina (ILMN). Read Mo...

Current Quarter	$2.4	Next Quarter	$2.86
Current Year	$10.76	Next Year	$11.94
QoQ Growth	+19.2%	YoY Growth	+11.0%
3Y EPS CAGR	+57.9%	Target Price	$242.38
Consensus	Buy	Upside	+20.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CAH	$200.91	+0.11%	426.76K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CAH	$200.91	+0.1%	426.76K
3
4
5
6

CAH

CAH

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Cardinal Health Inc. Data in Excel

Get Cardinal Health Inc. Data in Excel